Disease | lymphoma, non-hodgkin |
Symptom | C0746883|febrile neutropenia |
Sentences | 3 |
PubMedID- 24684228 | We conducted a cohort study to examine the association between a wide variety of chronic comorbidities and risk of febrile neutropenia (fn) in patients with non-hodgkin lymphoma (nhl) from 2000 to 2009 treated with chemotherapy at kaiser permanente southern california. |
PubMedID- 23452152 | External validation of a risk model of febrile neutropenia occurrence in patients with non-hodgkin lymphoma. |
PubMedID- 22972488 | Primary prophylaxis with granulocyte colony-stimulating factor (gcsf) reduces the incidence of febrile neutropenia in patients with non-hodgkin lymphoma (nhl) receiving chop chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis. |
Page: 1